NOT-OD-06-046: Change in Funding Opportunity Announcements That Use R03, R21, R33, and R34 Grant Mechanisms: Transition to Electronic Submission Using SF424 (R&R) Grant Application Package

Change in Funding Opportunity Announcements That Use R03, R21, R33, and R34 Grant Mechanisms: Transition to Electronic Submission Using SF424 (R&R) Grant Application Package

Notice Number: NOT-OD-06-046

Key Dates
Release Date: March 2, 2006

Issued by
National Institutes of Health (NIH), (http://www.nih.gov/)
Agency for Healthcare Research and Quality (AHRQ), (http://www.ahrq.gov/)
Centers for Disease Control and Prevention (CDC), (http://www.cdc.gov/)

The purpose of this Notice is to announce the following changes regarding funding opportunity announcements (FOAs) that utilize the Small Research Grant (R03), Exploratory/Developmental Research Grant (R21), the Phased Innovation Award (R21/R33), and the NIH Clinical Trial Planning Grant (R34) mechanisms

Effective June 1, 2006, R03 and R21 paper applications will no longer be accepted by the NIH, AHRQ or CDC. See http://grants.nih.gov/grants/guide/notice-files/NOT-OD-05-067.html. We are transitioning to electronic submission on the SF424 Research and Research Related (R&R) application form through Grants.gov by mechanism, which requires that we expire and/or issue separate FOAs for each mechanism to accommodate the new process. The use of parent FOAs will provide a means for standardizing the R03 and R21 application characteristics, requirements, preparation, and review procedures. These parent announcements accommodate investigator-initiated (unsolicited) applications and allow Institutes/Centers (ICs)/Agencies to describe how they use each mechanism and highlight their specific areas of scientific interest within a single FOA. Note, currently, there is not a Parent R34 FOA; each IC plans to issue separate R34 announcements.

The FOAs identified below are grouped in three categories according to the current plan of action. Any changes from the current plan will be reflected on individual FOAs.

Those that will expire effective March 2, 2006.
Those for which the Parent R03 and Parent R21 FOAs now include the scientific opportunities from currently published FOAs. Note: There will not be a Parent R34. Each IC will issue separate R34 announcements.
Those that will be reissued on or after March 2, 2006.

Where noted, R01 and other mechanisms that have not transitioned to electronic grant submission will continue to be accepted by the NIH in response to the FOAs shown below, but applicants MUST use the PHS 398 application in paper format until the mechanism transitions to the SF424 (R&R) electronic format. See http://era.nih.gov/ElectronicReceipt/files/timeline_adjustments_to_r01.htm. Specifically, R01 applications must be submitted electronically effective February 1, 2007 for new applications and March 1, 2007 for resubmission, competing renewal, and supplemental applications. The current schedule and other important information related to NIH’s transition from the PHS398 paper application to the SF424 (R&R) electronic application is available at: http://era.nih.gov/ElectronicReceipt/.

Over time, NIH will transition all funding mechanisms to the SF424 (R&R) form and electronic submission through Grants.gov. For now we are seeking to bring individual mechanisms into this new unified process in a measured way to ensure that the NIH can accept the applications without difficulty and that institutions/organizations have time to experience the new electronic ways of doing business.

1. FOAs that expire effective March 2, 2006.

Applicants interested in submitting investigator-initiated research projects in the following scientific areas are encouraged to contact IC program staff identified in the FOA number below.

FOA Number	Mechanism	Title
PA-03-079	R01, R21	EMERGING TECHNOLOGIES FOR THE STUDY OF REPRODUCTIVE NEUROENDOCRINOLOGY
PA-03-100	R21	NIGMS EXPLORATORY STUDIES FOR HIGH IMPACT/HIGH RISK RESEARCH
PA-03-163	R01, R03	NUTRITION AND THE DEVELOPMENT, TREATMENT, AND PREVENTION OF HIV DISEASE IN WOMEN, INFANTS, AND CHILDREN
PA-04-056	R01, R03	ENDOMETRIAL CELL FUNCTION
PA-05-001	R01, R21, P01	METALS IN MEDICINE Note: Only expiring for R03/R21. The R01 and P01 mechanisms will continue to be accepted using paper PHS 398 application.
PA-05-075	R01, R21	NEUROLOGIC MOTOR SPEECH DISORDERS AND SPEECH MOTOR CONTROL Note: Only expiring for R03/R21. The R01 mechanism will continue to be accepted using paper PHS 398 application.
PAR-03-019	R03	NEI SMALL RESEARCH GRANTS FOR DATA ANALYSIS (R03)
PAS-03-081	R01, R21	ALTERNATIVE TEST MODELS FOR ASSESSING GENITAL IRRITATION OF MICROBICIDAL/SPERMICIDAL PRODUCTS
PAS-03-122	R01, R21	FRAILTY IN OLD AGE: PATHOPHYSIOLOGY AND INTERVENTIONS
PAS-03-165	R01, R21	NEUROPROTECTIVE CNS BARRIERS IN NEUROLOGICAL DISEASES
PAS-03-168	R01, R03	ENROLLING WOMEN AND MINORITIES IN HIV/AIDS RESEARCH TRIALS

2. The following FOAs are now part of the Parent R03 and Parent R21.
Note: Applicants interested in the specific opportunities listed below must apply electronically using the application package from the Parent R03 or Parent R21.
(R01 and P01 applications will continue to be accepted using the paper PHS 398.)

FOA Number	Mechanism	Title
PA-03-015	R21	NHLBI INNOVATIVE RESEARCH GRANT PROGRAM
PA-03-058	R21	EXPLORATORY/DEVELOPMENTAL (R21) BIOENGINEERING RESEARCH GRANTS (EBRG)
PA-03-061	R01, R03, R21	EPIDEMIOLOGY OF ALCOHOL CONSUMPTION AND ALCOHOL-RELATED PROBLEMS IN OLDER PERSONS
PA-03-088	R01, R21, R03	TREATMENT OF ADOLESCENTS WITH ALCOHOL USE DISORDERS
PA-03-107	R21	NIH EXPLORATORY/DEVELOPMENTAL RESEARCH GRANT AWARD
PA-03-108	R03	NIH SMALL RESEARCH GRANT PROGRAM
PA-03-111	R01, R03, R21	RESEARCH ON ADHERENCE TO INTERVENTIONS FOR MENTAL DISORDERS
PA-03-113	R01, R03, R21	DEVELOPMENTAL PSYCHOPHARMACOLOGY
PA-03-132	R21	SECONDARY ANALYSIS OF EXISTING ALCOHOL AND HIV/AIDS DATA SETS
PA-03-141	R01, R21	GENE-ENVIRONMENT INTERACTIONS INFLUENCING ALCOHOL-RELATED PHENOTYPES AND DISEASES
PA-03-144	R01, R03, R21	RESEARCH ON COMMUNITY REINTEGRATION FOR PEOPLE WITH PSYCHIATRIC DISABILITIES
PA-03-161	R01, R03, R21, R34	RESEARCH ON THE REDUCTION AND PREVENTION OF SUICIDALITY
PA-03-162	R01, R21	FINDING GENES FOR ALCOHOL-RELATED BEHAVIORS AND RISK FOR ALCOHOLISM
PA-03-169	R01, R03	BASIC AND TRANSLATIONAL RESEARCH IN EMOTION
PA-03-171	R21	EXPLORATORY AND DEVELOPMENTAL RESEARCH GRANTS FOR INVESTIGATIONS IN RARE DISEASES
PA-04-005	R01, R21	MECHANISMS OF ALCOHOLIC PANCREATITIS
PA-04-019	R01, R03, R34	EFFECTIVENESS, PRACTICE, AND IMPLEMENTATION IN CMHS CHILDREN’s SERVICE SITES
PA-04-024	R01, R03, R21	HIV/AIDS, SEVERE MENTAL ILLNESS AND HOMELESSNESS
PA-04-044	R01, R03, R21, R34	RESEARCH ON PSYCHOPATHOLOGY IN INTELLECTUAL DISABILITIES (MENTAL RETARDATION)
PA-04-048	R01, R03, R21	ALCOHOL ABUSE AND HIV/AIDS IN RESOURCE-POOR SOCIETIES
PA-04-051	R03	ELSI SMALL GRANT RESEARCH PROGRAM (R03)
PA-04-061	R01, R03, R21	RESEARCH ON RURAL MENTAL HEALTH AND DRUG ABUSE DISORDERS
PA-04-067	R01, R03, R21	PHARMACOTHERAPY FOR COMORBID ALCOHOL AND DRUG USE DISORDERS
PA-04-119	P01, R01, R21	BIODEFENSE AND EMERGING INFECTIOUS DISEASE RESEARCH OPPORTUNITIES
PA-04-150	R01, R34	DESIGN, MEASUREMENT AND STATISTICS IN COMMUNITY MH RESEARCH
PA-04-154	R01, R21	HIV INFECTION OF THE CENTRAL NERVOUS SYSTEM
PA-05-007	R01, R03, R21	CO-OCCURRING MENTAL ILLNESS, ALCOHOL AND/OR DRUG ABUSE & MEDICAL CONDITIONS
PA-05-008	R01, R03, R34	RESEARCH ON MENTAL HEALTH ECONOMICS
PA-05-018	R01, R03, R34	RESEARCH ON CO-MORBID MENTAL AND OTHER PHYSICAL DISORDERS
PA-05-019	R01, R03, R34	HEALTH BEHAVIOR CHANGE IN PEOPLE WITH MENTAL DISORDERS
PA-05-037	R01, R03, R34	FUNCTIONAL ASSESSMENT OF PEOPLE WITH MENTAL DISORDERS
PA-05-043	R21	DIRECTED STEM CELL DIFFERENTIATION FOR CELL-BASED THERAPIES FOR HEART, LUNG, AND BLOOD, AND AGING DISEASES
PA-05-046	R01, R21	RESEARCH ON SLEEP AND SLEEP DISORDERS
PA-05-054	R01, R03, R21	FUNCTIONAL LINKS BETWEEN THE IMMUNE SYSTEM, BRAIN FUNCTION AND BEHAVIOR
PA-05-074	R01, R03, R21	MECHANISMS OF ALCOHOL-INDUCED TISSUE INJURY
PA-05-088	R01, R03, R21	SECONDARY ANALYSIS OF EXISTING ALCOHOL EPIDEMIOLOGY DATA
PA-05-089	R01, R21	NUTRITION AND DIET IN THE CAUSATION, PREVENTION, AND MANAGEMENT OF HEART FAILURE
PA-05-104	R01, R03, R21, R34	TREATMENT-EMERGENT ADVERSE EFFECTS OF PSYCHOTROPIC MEDICATION
PA-05-119	R01, R03, R21	MECHANISMS OF ALCOHOLIC AND NONALCOHOLIC FATTY LIVER (STEATOSIS)
PA-05-146	R01, R03, R21	STRUCTURAL INTERVENTIONS, ALCOHOL USE, AND RISK OF HIV/AIDS
PA-05-164	R01, R03, R21	RECENT HIV INFECTION: NEW PREVENTION CHALLENGES AND OPPORTUNITIES

3. FOAs that will be reissued on or after March 2, 2006.

Note: Applicants interested in the specific opportunities listed below must apply electronically using the application package for that specific FOA. Other mechanisms (e.g., R01, P01) that have not yet transitioned to electronic submission will continue to be accepted under the existing FOAs below (e.g., PA-06-040) using the paper PHS 398 application.

FOA Number	Mechanism	Title
PA-03-065	R01, R21	CALCIUM OXALATE STONE DISEASES
PA-03-073	R01, R21	ADVANCES IN POLYCYSTIC KIDNEY DISEASE
PA-03-076	R01, R21	BASIC AND CLINICAL STUDIES OF CONGENITAL URINARY TRACT OBSTRUCTION
PA-03-091	R01, R21	ANCILLARY STUDIES OF KIDNEY DISEASE ACCESSING INFORMATION FROM CLINICAL TRIALS, EPIDEMIOLOGICAL STUDIES, AND DATABASES
PA-03-112	R21, R33	DEVELOPMENT AND APPLICATION OF PET AND SPECT LIGANDS FOR BRAIN IMAGING STUDIES (PHASED INNOVATION AWARD)
PA-03-116	R01, R21	TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN SEMEN
PA-03-126	R01, R03, R21	BEHAVIORAL THERAPIES DEVELOPMENT PROGRAM
PA-03-135	R01, R03, R21	WOMEN'S MENTAL HEALTH IN PREGNANCY AND THE POSTPARTUM PERIOD
PA-03-139	R01, R03, R21	WOMEN, GENDER DIFFERENCES AND DRUG ABUSE
PA-03-143	R01, R03, R21, R34	WOMEN'S MENTAL HEALTH AND SEX/GENDER DIFFERENCES RESEARCH
PA-03-145	R01, R21	UBIQUITIN AND UBIQUITIN-LIKE MODIFICATIONS REGULATING DISEASE PROCESSES
PA-03-150	R01, R21	ERYTHROID LINEAGE MOLECULAR TOOLBOX
PA-03-151	R21	PROTEOMICS IN AUDITORY DEVELOPMENTAL AND DISEASE PROCESSES
PA-03-152	R01, R21	BIOBEHAVIORAL PAIN RESEARCH
PA-03-156	R01, R21	INSULIN SIGNALING AND RECEPTOR CROSS-TALK
PA-03-159	R01, R21	CHRONIC ILLNESS SELF-MANAGEMENT IN CHILDREN
PA-03-167	R01, R21	AGING MUSCULOSKELETAL AND SKIN EXTRACELLULAR MATRIX
PA-03-170	R01, R21	HEALTH PROMOTION AMONG RACIAL AND ETHNIC MINORITY MALES
PA-04-006	R01, R21	NEUROTECHNOLOGY RESEARCH, DEVELOPMENT, AND ENHANCEMENT
PA-04-007	R01, R03, R21	DRUG ABUSE ASPECTS OF HIV/AIDS AND OTHER INFECTIONS
PA-04-012	R01, R21	CANCER SURVEILLANCE USING HEALTH CLAIMS-BASED DATA SYSTEM
PA-04-017	R01, R21	STUDIES OF THE ECONOMICS OF CANCER PREVENTION, SCREENING, AND CARE
PA-04-021	R03	SMALL GRANTS IN OCCUPATIONAL SAFETY AND HEALTH RESEARCH (R03)
PA-04-027	R01, R21	REDUCING PRETERM & LOW BIRTH WEIGHT IN MINORITY FAMILIES
PA-04-030	R21	NIOSH EXPLORATORY/DEVELOPMENTAL GRANT PROGRAM (R21)
PA-04-033	R01, R21	DIET COMPOSITION AND ENERGY BALANCE
PA-04-034	R21	EXPLORATORY GRANTS FOR BEHAVIORAL RESEARCH IN CANCER CONTROL
PA-04-035	R21	CIRCULATING CELLS IN CANCER DETECTION
PA-04-043	R01, R21	RESEARCH GRANTS FOR STUDIES OF HEPATITIS C IN THE SETTING OF RENAL DISEASE
PA-04-045	R21	IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS
PA-04-049	R01, R03, R21	REPRODUCTIVE GENETICS AND EPIGENETICS
PA-04-053	R21	DEVELOPMENTAL PROJECTS IN COMPLEMENTARY APPROACHES TO CANCER CARE
PA-04-057	R01, R21	IMPROVING CARE FOR DYING CHILDREN AND THEIR FAMILIES
PA-04-074	R01, R21	HEALTH DISPARITIES IN NIDDK DISEASES
PA-04-075	R01, R03, R21, R34	MENTAL HEALTH CONSEQUENCES OF VIOLENCE AND TRAUMA
PA-04-081	R01, R21	PROTEOMICS: DIABETES, OBESITY, AND ENDOCRINE, DIGESTIVE, KIDNEY, UROLOGIC, AND HEMATOLOGIC DISEASES
PA-04-084	R01, R03	PSYCHOPHARMACOLOGY OF WIDELY AVAILABLE PSYCHOACTIVE NATURAL PRODUCTS
PA-04-085	R01, R03, R21	RESEARCH ON AUTISM AND AUTISM SPECTRUM DISORDERS
PA-04-088	R01, R21	NON-INVASIVE METHODS FOR DIAGNOSIS AND PROGRESSION OF DIABETES, KIDNEY, UROLOGICAL, HEMATOLOGICAL AND DIGESTIVE DISEASES
PA-04-092	R01, R21	LONG-TERM WEIGHT MAINTENANCE: BASIC AND CLINICAL STUDIES
PA-04-093	R01, R21	NOVEL APPROACHES TO STUDY POLYMICROBIAL DISEASES
PA-04-095	R21, R33	NOVEL TECHNOLOGIES FOR IN VIVO IMAGING (R21/R33)
PA-04-098	R01, R21	HETEROGENEITY OF FAT DEPOTS: UNDERLYING BASIS AND ASSOCIATION WITH MORBIDITY
PA-04-099	R01, R03, R21	DIET, EPIGENETIC EVENTS, AND CANCER PREVENTION
PA-04-100	R01, R03, R21	EPIDEMIOLOGY OF DRUG ABUSE
PA-04-101	R01, R21	CHARACTERIZATION, BEHAVIOR AND PLASTICITY OF PLURIPOTENT STEM CELLS
PA-04-102	R21, R33	PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION
PA-04-103	R01, R21	TESTING TOBACCO PRODUCTS PROMOTED TO REDUCE HARM
PA-04-108	R21	INNOVATIVE AND EXPLORATORY RESEARCH IN DIGESTIVE DISEASES AND NUTRITION
PA-04-109	R01, R03, R21	CROSS-DISCIPLINARY TRANSLATIONAL RESEARCH AT NIH
PA-04-110	R01, R03, R21	PRESCRIPTION DRUG ABUSE
PA-04-113	R01, R03	THE SCIENCE AND ECOLOGY OF EARLY DEVELOPMENT (SEED)
PA-04-114	R01, R03, R21	EXFOLIATED CELLS, BIOACTIVE FOOD COMPONENTS, AND CANCER
PA-04-115	R01, R21	RELIGIOUS ORGANIZATIONS AND HIV
PA-04-118	R01, R21	CELL LINEAGE AND DEVELOPMENTAL STUDIES IN HEARING AND BALANCE
PA-04-121	R01, R21	UNDERSTANDING MECHANISMS OF HEALTH RISK BEHAVIOR CHANGE IN CHILDREN AND ADOLESCENTS
PA-04-123	R03	SOCIOBEHAVIORAL DATA ANALYSIS AND ARCHIVING IN AGING
PA-04-124	P01, P30, R01, R21, U01	STUDIES OF ENERGY BALANCE AND CANCER IN HUMANS
PA-04-125	R01, R21	NOVEL APPROACHES TO ENHANCE ANIMAL STEM CELL RESEARCH
PA-04-134	R21	PILOT STUDIES: ORAL COMPLICATIONS OF CANCER THERAPIES
PA-04-137	R21	EXPLORATORY GRANT PROGRAM IN DIABETES ENDOCRINOLOGY AND METABOLISM
PA-04-139	R21	JOINT DEGENERATION: MOUSE MODELS
PA-04-144	R21	PILOT AND FEASIBILITY PROGRAM IN HEMATOLOGIC DISEASES
PA-04-145	R01, R03, R21	SCHOOL-BASED INTERVENTIONS TO PREVENT OBESITY
PA-04-146	R21	PILOT AND FEASIBILITY PROGRAM IN UROLOGY
PA-04-152	R01, R03, R21	MDMA: RESEARCH AREAS NEEDING MORE EMPHASIS
PA-04-153	R01, R21	HEALTH DISPARITIES AMONG MINORITY AND UNDERSERVED WOMEN
PA-04-157	R01,R21	RESEARCH ON MALIGNANCIES IN AIDS AND ACQUIRED IMMUNE SUPPRESSION
PA-04-158	R01, R03, R21	ANCILLARY STUDIES TO THE AD NEUROIMAGING INITIATIVE
PA-05-004	R01, R21	SYMPTOM CLUSTERS IN CANCER AND IMMUNE DISORDERS
PA-05-006	R03, R21	THE EFFECT OF RACIAL AND ETHNIC DISCRIMINATION/BIAS ON HEALTH CARE DELIVERY
PA-05-009	R01, R21	RESEARCH ON THE ECONOMICS OF DIET, ACTIVITY, AND ENERGY BALANCE
PA-05-016	R01, R21	DECISION MAKING IN HEALTH: BEHAVIOR MAINTENANCE
PA-05-017	R01, R21	DECISION MAKING IN CANCER: SINGLE-EVENT DECISIONS
PA-05-030	R01, R03, R21	CHRONIC FATIGUE SYNDROME: PATHOPHYSIOLOGY AND TREATMENT
PA-05-033	R01, R03, R21	MEN'S HETEROSEXUAL BEHAVIOR AND HIV INFECTION
PA-05-035	R01, R21	PROBIOTICS FOR PEDIATRIC ILLNESSES
PA-05-036	P01, R01, R03, R21	RETIREMENT ECONOMICS
PA-05-038	R01, R21	MUSCULAR DYSTROPHY: PATHOGENESIS AND THERAPIES
PA-05-045	R01, R21	MECHANISMS OF ADVERSE DRUG EFFECTS IN CHILDREN
PA-05-048	R01, R21	PROTEIN BIOMARKERS OF INFECTION-ASSOCIATED CANCERS
PA-05-059	R01, R21	IN UTERO EXPOSURE TO BIOACTIVE FOOD COMPONENTS AND MAMMARY CANCER RISK
PA-05-062	R01, R21	CORRELATIVE STUDIES WITH SPECIMENS FROM MULTI-SITE TRIALS
PA-05-086	R01, R21	STEM CELLS AND CANCER
PA-05-090	R01, R03, R21	METHODOLOGY AND MEASUREMENT IN THE BEHAVIORAL AND SOCIAL SCIENCES
PA-05-093	R01, R03	SECONDARY DATA ANALYSES BASED ON THE NICHD STUDY OF EARLY CHILD CARE AND YOUTH DEVELOPMENT
PA-05-094	R21	SECONDARY ANALYSES IN OBESITY, DIABETES, DIGESTIVE AND KIDNEY DISEASES
PA-05-095	R01, R21	COLLABORATIVE AWARDS IN EPILEPSY RESEARCH FOR JUNIOR INVESTIGATORS
PA-05-096	R01, R03, R21	MECHANISMS OF TRANSMISSION AND DISSEMINATION OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSES)
PA-05-097	R01, R03, R21	COMPLEMENTARY AND ALTERNATIVE MEDICINE FOR SUBSTANCE AND ALCOHOL RELATED DISORDERS
PA-05-098	R01, R21	DEVELOPMENT OF DISEASE BIOMARKERS
PA-05-099	R01, R03, R21	INHALANT ABUSE: SUPPORTING BROAD-BASED RESEARCH APPROACHES
PA-05-103	R21	PILOT AND FEASIBILITY PROGRAM RELATED TO THE KIDNEY
PA-05-108	R01, R03, R21	SHARED NEUROBIOLOGY OF FRAGILE X SYNDROME AND AUTISM
PA-05-111	R01, R03, R21	ECONOMICS OF PREVENTION AND TREATMENT SERVICES FOR DRUG AND ALCOHOL ABUSE
PA-05-116	R03, R21	PILOT STUDIES IN PANCREATIC CANCER
PA-05-118	R01, R03, R21	DRUG ABUSE PREVENTION INTERVENTION RESEARCH
PA-05-125	R01, R21	DIET-INDUCED CHANGES IN INFLAMMATION AS DETERMINANTS OF COLON CANCER
PA-05-136	R01, R21	TESTING STEM CELL THERAPY IN MOUSE MODELS OF PREMATURE AGING
PA-05-137	R01, R21	ETIOLOGY, PREVENTION, AND TREATMENT OF HEPATOCELLULAR CARCINOMA (R01 AND R21)
PA-05-139	R01, R03, R21	HEALTH SERVICES RESEARCH ON THE PREVENTION AND TREATMENT OF DRUG AND ALCOHOL ABUSE
PA-05-141	R01, R15, R21	TITLE: BASIC AND PRECLINICAL RESEARCH ON COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM)
PA-05-142	R01, R21	BIOBEHAVIORAL METHODS TO IMPROVE OUTCOMES RESEARCH
PA-05-154	R01, R21	STRUCTURAL ANALYSES OF THE LIGAND-BINDING PROPERTIES OF TASTE AND SMELL RECEPTORS
PA-05-155	R01, R21	THE SECRETORY PATTERN OF SENESCENT CELLS
PA-05-162	R01, R03, R21, R34	NEURODEVELOPMENT AND NEUROENDOCRINE SIGNALING IN ADOLESCENCE: RELEVANCE TO MENTAL HEALTH
PA-05-165	R21	EXPLORATORY STUDIES IN CANCER DETECTION, DIAGNOSIS, AND PROGNOSIS
PA-06-040	R01, R21	NIDCD PATIENT-ORIENTED RESEARCH GRANT
PA-06-082	R03	RESEARCH ON SOCIAL WORK PRACTICE AND CONCEPTS IN HEALTH (R03)
PA-06-083	R21	RESEARCH ON SOCIAL WORK PRACTICE AND CONCEPTS IN HEALTH (R21)
PA-06-098	R21	PARENTING CAPACITIES AND HEALTH OUTCOMES IN YOUTHS AND ADOLESCENTS (R21)
PA-06-101	R21	RESEARCH ON CLINICAL DECISION MAKING IN LIFE-THREATENING ILLNESS (R21)
PA-06-106	R03	RESEARCH ON THE COGNITIVE SEQUELAE OF PARKINSON'S DISEASE (R03)
PA-06-107	R21	RESEARCH ON THE COGNITIVE SEQUELAE OF PARKINSON'S DISEASE
PA-06-109	R21, R33	PHASED INNOVATION AWARDS IN AIDS VACCINE RESEARCH
PAR-01-040	R03	AHRQ SMALL RESEARCH GRANT PROGRAM
PAR-02-133	R03, R21	RAPID ASSESSMENT POST-IMPACT OF DISASTER
PAR-03-045	R01, R21	NANOSCIENCE AND NANOTECHNOLOGY IN BIOLOGY AND MEDICINE
PAR-03-059	R21	INTERNATIONAL COLLABORATIVE ORAL HEALTH RESEARCH PLANNING GRANT
PAR-03-078	R34	FROM INTERVENTION DEVELOPMENT TO SERVICES: EXPLORATORY RESEARCH GRANTS (R34)
PAR-03-146	R03	BEHAVIORAL SCIENCE TRACK AWARD FOR RAPID TRANSITION (B/START) NIDA
PAR-03-153	R21	NCCAM EXPLORATORY/DEVELOPMENTAL GRANT FOR CLINICAL STUDIES (R21)
PAR-04-010	R03	BEHAVIORAL SCIENCE TRACK AWARD FOR RAPID TRANSITION (B/START)
PAR-04-062	R03	NIDCD SMALL GRANT (R03) PROGRAM
PAR-04-070	R03	SMALL GRANT PROGRAM FOR NIDDK K08/K23 RECIPIENTS
PAR-04-082	R03	SMALL CLINICAL GRANTS IN DIGESTIVE DISEASES, NUTRITION AND OBESITY
PAR-04-087	R21	GENERAL CLINICAL RESEARCH CENTER COMPLEMENTARY AND ALTERNATIVE MEDICINE RESEARCH PROGRAM
PAR-04-091	R03	NIDCR SMALL RESEARCH GRANTS FOR DATA ANALYSIS AND STATISTICAL METHODOLOGY (R03)
PAR-04-117	R03	UNDERSTANDING AND PROMOTING HEALTH LITERACY (R03)
PAR-04-133	R21	CLINICAL TRIALS: ORAL COMPLICATIONS OF CANCER THERAPY
PAR-04-138	R21	DEVELOPMENTAL INFRASTRUCTURE FOR POPULATION
PAR-04-147	R03	CANCER PREVENTION RESEARCH SMALL GRANT PROGRAM
PAR-04-155	R21	QUICK-TRIALS FOR NOVEL CANCER THERAPIES: EXPLORATORY GRANTS
PAR-04-159	R03	SMALL GRANTS PROGRAM FOR CANCER EPIDEMIOLOGY
PAR-05-020	R21	NIDCR EXPLORATORY AND DEVELOPMENTAL GRANTS IN CLINICAL RESEARCH
PAR-05-023	R01, R21	NIDCD TRANSLATIONAL RESEARCH GRANTS
PAR-05-026	R01, R21	COMMUNITY PARTICIPATION IN RESEARCH
PAR-05-057	P01, P41, P50, P60, R01, R33	CONTINUED DEVELOPMENT AND MAINTENANCE OF SOFTWARE
PAR-05-072	R03	INTERNATIONAL RESEARCH COLLABORATION BASIC BIOMEDICAL (FIRCA-BB)
PAR-05-073	R03	INTERNATIONAL RESEARCH COLLABORATION BEHAVIORAL, SOCIAL SCIENCES (FIRCA-BSS)
PAR-05-100	R01, R21	BRAIN DISORDERS IN THE DEVELOPING WORLD: RESEARCH ACROSS THE LIFESPAN
PAR-05-112	R34	NIAID CLINICAL TRIAL PLANNING (R34) GRANTS
PAR-05-114	R21	QUICK-TRIALS FOR IMAGING AND IMAGE-GUIDED INTERVENTIONS: EXPLORATORY GRANTS
PAR-05-150	R01, R03, R21, R34	MECHANISM FOR TIME-SENSITIVE RESEARCH OPPORTUNITIES
PAR-05-152	R21	CAM AT MINORITY OR HEALTH DISPARITIES RESEARCH CENTERS
PAR-05-157	R21	NINDS EXPLORATORY/DEVELOPMENTAL PROJECTS IN TRANSLATIONAL RESEARCH
PAR-05-168	R01, R21	INTERDISCIPLINARY PARTNERSHIPS IN ENVIRONMENTAL HEALTH SCIENCES
PAR-06-025	R21	NIDCR CLINICAL PILOT DATA GRANT
PAR-06-026	R21	NIDCR CLINICAL TRIAL PLANNING GRANT
PAR-06-043	R21	EXPLORATORY/DEVELOPMENTAL PROGRAM FOR TRANSLATIONAL RESEARCH IN MUSCULAR DYSTROPHY
PAR-06-059	R21	INNOVATIVE THERAPIES AND CLINICAL STUDIES FOR SCREENABLE DISORDERS (R21)
PAR-06-061	R03	INNOVATIVE THERAPIES AND CLINICAL STUDIES FOR SCREENABLE DISORDERS (R03)
PAR-06-071	R03	DISSEMINATION AND IMPLEMENTATION RESEARCH IN HEALTH (R03)
PAR-06-072	R21	DISSEMINATION AND IMPLEMENTATION RESEARCH IN HEALTH (R21)
PAR-06-073	R03	SMALL GRANTS FOR BEHAVIORAL RESEARCH IN CANCER CONTROL (R03)
PAR-06-075	R03	COLLABORATIVE CAM RESEARCH DEVELOPMENT CAPABILITY ENHANCEMENT GRANT AT MINORITY-SERVING INSTITUTIONS (R03)
PAR-06-092	R03	IMAGING - SCIENCE TRACK AWARD FOR RESEARCH TRANSITION (I/START) [R03]
PAR-06-111	R03	NIAMS SMALL GRANT PROGRAM FOR NEW INVESTIGATORS
PAR-06-112	R21	PILOT AND FEASIBILITY CLINICAL RESEARCH GRANTS IN KIDNEY OR UROLOGIC DISEASES
PAS-03-092	R01, R21	GENE DISCOVERY FOR COMPLEX NEUROLOGICAL AND NEUROBEHAVIORAL DISORDERS
PAS-03-173	R01, R21	NEUROBIOLOGY OF PERSISTENT PAIN MEDIATED BY THE TRIGEMINAL NERVE
PAS-04-066	R21	SIMIAN MODELS FOR THE ORAL BIOLOGY OF HIV INFECTION AND AIDS-RELATED ORAL COMPLICATIONS
PAS-04-072	R01, R21	NEUROVASCULAR MECHANISMS OF BRAIN FUNCTION AND DISEASE
PAS-04-079	R01, R21	UNDERSTANDING AND PREVENTING BRAIN TUMOR DISPERSAL
PAS-04-111	R03	NIAID INTERNATIONAL RESEARCH IN INFECTIOUS DISEASES (IRID) R03 PROGRAM
PAS-04-120	R01, R21	CNS THERAPY DEVELOPMENT FOR LYSOSOMAL STORAGE DISORDERS
PAS-04-130	R01, R21	COLLABORATIVE RESEARCH IN STEM CELL BIOLOGY
PAS-04-149	R01, R21	GENETICS AND PATHOBIOLOGY OF VASCULAR COGNITIVE IMPAIRMENT
PAS-05-002	R01, R21	AXONAL DAMAGE IN MULTIPLE SCLEROSIS: STRATEGIES FOR PROTECTION AND REPAIR
PAS-05-022	R21	R21 GRANTS FOR ALZHEIMER'S DISEASE DRUG DISCOVERY
PAS-05-024	R01, R03, R21	BASIC AND CLINICAL RESEARCH ON RETT SYNDROME AND MECP2
PAS-05-078	R01, R03, R21	NON-HUMAN LENTIVIRAL MODELS OF THE NEUROLOGICAL COMPLICATIONS OF AIDS
PAS-05-085	R01, R03, R21	UNDERSTANDING AND TREATING TUBEROUS SCLEROSIS COMPLEX
PAS-05-092	R01, R03, R21	INTERACTIONS BETWEEN STEM AND PROGENITOR CELLS AND THE MICROENVIRONMENT IN VIVO

Inquiries

Please direct inquiries regarding this notice to:

Jo Anne Goodnight
Acting Director, Office of Extramural Programs
NIH SBIR/STTR Program Coordinator
Office of Extramural Research
National Institutes of Health
Department of Health and Human Services
6705 Rockledge Drive
Rockledge I Building, Room 3534
Bethesda MD 20892
ph: 301-435-2688
fax: 301-480-0146
email: OEPmailbox@mail.nih.gov